SARS-CoV-2 Antigen Rapid Qualitative Test Type B

SARS-CoV-2 Antigen Rapid Qualitative Test Type A

2 in 1 (CEA/AFP) Rapid Quantitative Test

Biotime 2 in 1 (CEA/AFP) test kit has very important guiding significance in the diagnosis of liver cancer and can improve the accuracy of clinical diagnosis.

β-HCG Rapid Quantitative Test

β-HCG is a fluorescent immunoassay for the quantitative measurement of β-HCG level in human serum and whole blood. This test is performed to help diagnose pregnancy if a woman is to undergo a medical treatment, be placed on certain drugs, or have other testing, such as x-rays, that might harm the developing baby.

CEA Rapid Quantitative Test

Carcinoembryonic antigen (CEA) is a protein normally found in very low levels in the blood of adults. The CEA blood level may be increased in certain types of cancer and non-cancerous (benign) conditions. A CEA test is most commonly used for colorectal cancer.

HSV-2 IgG/IgM Rapid Test (Fluorescence Immunoassay)

The HSV-2 IgG/IgM Rapid Test is an in vitro immunoassay for the qualitative determination of IgG and IgM class antibodies to HSV2 in human serum. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection. The HSV-2 IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Herpes simplex viruses2 (HSV-2) infection -For in vitro diagnostic use only. For professional use only.

BIOT-YG-I FIA Immunoassay Analyzer (Fluorescence Immunoassay Analyzer)

BIOT-YG-I is a fluorescence immunoassay system with single channel that measures the quantitative concentration of a targeted analyte in human blood and urine.

2 in 1(CRP/SAA) Rapid Quantitative Test

Biotime 2 in 1 test kit can help the operator to distinguish the bacterial infection and viral infection, and improve the accuracy of clinical diagnosis of infectious diseases.

Myo Rapid Quantitative Test

Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type B